These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice. Chen XH, Sun RS, Hu JM, Mo ZY, Yang ZF, Jin GY, Guan WD, Zhong NS. Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980 [Abstract] [Full Text] [Related]
23. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice. Kinoshita K, Aono Y, Azuma M, Kishi J, Takezaki A, Kishi M, Makino H, Okazaki H, Uehara H, Izumi K, Sone S, Nishioka Y. Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017 [Abstract] [Full Text] [Related]
30. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Wu Z, Yang L, Cai L, Zhang M, Cheng X, Yang X, Xu J. Respir Res; 2007 Jan 07; 8(1):1. PubMed ID: 17207287 [Abstract] [Full Text] [Related]
31. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. Königshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F, Fink L, Seeger W, Schaefer L, Günther A, Eickelberg O. J Clin Invest; 2009 Apr 07; 119(4):772-87. PubMed ID: 19287097 [Abstract] [Full Text] [Related]
32. The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Königshoff M, Wilhelm A, Jahn A, Sedding D, Amarie OV, Eul B, Seeger W, Fink L, Günther A, Eickelberg O, Rose F. Am J Respir Cell Mol Biol; 2007 Dec 07; 37(6):640-50. PubMed ID: 17630322 [Abstract] [Full Text] [Related]
34. p38 MAPK is Crucial for Wnt1- and LiCl-Induced Epithelial Mesenchymal Transition. Fang CX, Ma CM, Jiang L, Wang XM, Zhang N, Ma JN, Wu TH, Zhang ZH, Zhao GD, Zhao YD. Curr Med Sci; 2018 Jun 07; 38(3):473-481. PubMed ID: 30074215 [Abstract] [Full Text] [Related]
35. S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice. Nie Y, Yu K, Li B, Hu Y, Zhang H, Xin R, Xiong Y, Zhao P, Chai G. J Pharmacol Sci; 2019 Apr 07; 139(4):377-384. PubMed ID: 30928090 [Abstract] [Full Text] [Related]
38. Targeted inhibition of disheveled PDZ domain via NSC668036 depresses fibrotic process. Wang C, Dai J, Sun Z, Shi C, Cao H, Chen X, Gu S, Li Z, Qian W, Han X. Exp Cell Res; 2015 Feb 01; 331(1):115-122. PubMed ID: 25445788 [Abstract] [Full Text] [Related]
39. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats. Li S, Yang X, Li W, Li J, Su X, Chen L, Yan G. Respiration; 2012 Feb 01; 84(6):509-17. PubMed ID: 23006535 [Abstract] [Full Text] [Related]
40. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. Surendran K, Schiavi S, Hruska KA. J Am Soc Nephrol; 2005 Aug 01; 16(8):2373-84. PubMed ID: 15944336 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]